"
Combined Treatment Strategy and Outcome of High Risk Neuroblastoma: Experience of the Children’s Cancer Hospital-Egypt"
written by Emad Moussa, Mohamed Fawzy, Alaa Younis, Maged El Shafei, Mohamed Saad Zaghloul, Naglaa El Kinaai, Amal Refaat, Noha Atta, Alaa El Haddad,
published by
Journal of Cancer Therapy,
Vol.4 No.9, 2013
has been cited by the following article(s):
|
[1]
|
Mutational spectrum of
ATRX
aberrations in neuroblastoma and associated patient and tumor characteristics
Cancer Science,
2022
DOI:10.1111/cas.15363
|
|
|
|
|
[2]
|
Neuroblastoma: The basis for cure in limited‐resource settings
Pediatric Blood & Cancer,
2021
DOI:10.1002/pbc.28923
|
|
|
|
|
[3]
|
Neuroblastoma: The basis for cure in limited‐resource settings
Pediatric Blood & Cancer,
2021
DOI:10.1002/pbc.28923
|
|
|
|
|
[4]
|
Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta
Pediatric Hematology and Oncology,
2021
DOI:10.1080/08880018.2020.1850955
|
|
|
|
|
[5]
|
Neuroblastoma in Sudan: experience of a single institute
Sudanese Journal of Paediatrics,
2020
DOI:10.24911/SJP.106-1570515379
|
|
|
|
|
[6]
|
Management of neuroblastoma in limited-resource settings
World Journal of Clinical Oncology,
2020
DOI:10.5306/wjco.v11.i8.629
|
|
|
|